Literature DB >> 19151994

Increased level of (1,3)-beta-D-glucan in tear fluid of mycotic keratitis.

Yuichi Kaji1, Takahiro Hiraoka, Tetsuro Oshika.   

Abstract

PURPOSE: Increased concentration of (1,3)-beta-D-glucan, one of the major components of fungal cell walls, is detected in the serum of systemic fungal infection. In our study, the concentration of (1,3)-beta-D-glucan was measured in the tear fluid of patients with mycotic keratitis.
METHODS: Tear fluid was collected from patients with fungal keratitis (n = 4) and bacterial corneal ulcers (n = 4) with or without corneal scraping. In addition, tear fluid was collected from patients without corneal diseases.
RESULTS: The concentration of (1,3)-beta-D-glucan in tear fluid collected without corneal scraping was 4.0 +/- 3.5, 5.8 +/- 2.6, 184 +/- 128 pg/ml in the control, bacterial corneal ulcer, and mycotic keratitis samples respectively. The concentration of (1,3)-beta-D-glucan in tear fluid collected after scraping the corneal lesions with a tip of glass capillary was 4.4 +/- 1.3, 8.2 +/- 5.2 and >1,000 pg/ml in the control, bacterial ulcer, and mycotic keratitis samples respectively.
CONCLUSIONS: A significant increase in (1,3)-beta-D-glucan was detected in tear samples from patients with mycotic keratitis. Measuring the concentration of (1,3)-beta-D-glucan in tear fluid might be helpful in the diagnosis of mycotic keratitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19151994     DOI: 10.1007/s00417-008-1032-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  9 in total

1.  [Investigation of beta-D-glucan values in the vitreous].

Authors:  Masano Shimbo; Norihiko Ito; Kazuaki Kadonosono
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2002-09

2.  Determination of plasma (1-->3)-beta-D-glucan: a new diagnostic aid to deep mycosis.

Authors:  T Obayashi; M Yoshida; H Tamura; J Aketagawa; S Tanaka; T Kawai
Journal:  J Med Vet Mycol       Date:  1992

3.  Potential use of (1,3)-beta-D-glucan as target of diagnosis and treatment of keratomycosis.

Authors:  Yuichi Kaji; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Cornea       Date:  2004-11       Impact factor: 2.651

Review 4.  Non-culture based diagnostic tests for mycotic infections.

Authors:  E Reiss; T Obayashi; K Orle; M Yoshida; R M Zancopé-Oliveira
Journal:  Med Mycol       Date:  2000       Impact factor: 4.076

5.  Etiologic factors in tropical eye diseases.

Authors:  R Cordero-Moreno
Journal:  Am J Ophthalmol       Date:  1973-03       Impact factor: 5.258

Review 6.  Mycotic keratitis--an underestimated mycosis.

Authors:  P A Thomas
Journal:  J Med Vet Mycol       Date:  1994

7.  Ecological distribution of Fusarium solani and its opportunistic action related to mycotic keratitis in Cali, Colombia.

Authors:  R G Cuero
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

8.  Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes.

Authors:  T Obayashi; M Yoshida; T Mori; H Goto; A Yasuoka; H Iwasaki; H Teshima; S Kohno; A Horiuchi; A Ito
Journal:  Lancet       Date:  1995-01-07       Impact factor: 79.321

Review 9.  Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1-->3)-beta-D-glucan antigens.

Authors:  A Kedzierska; P Kochan; A Pietrzyk; J Kedzierska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.